Testa, R <br/><br/>
Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.  [electronic resource] 

 -  Diabetes, nutrition & metabolism  Aug 2004 
 - 217-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0394-3402 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antioxidants--pharmacology<br/>Diabetes Mellitus, Type 2--blood<br/>Dietary Supplements<br/>Female<br/>Genotype<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Polymorphism, Genetic<br/>Promoter Regions, Genetic<br/>Vitamin E--pharmacology